openPR Logo
Press release

The contract regulatory affairs-management services market for medical devices is estimated to be worth USD 820 million by 2030, growing at a CAGR of 6.9%, claims Roots Analysis

12-03-2020 07:13 AM CET | Health & Medicine

Press release from: Roots Analysis

The contract regulatory affairs-management services market

Over the years, outsourcing has become a popular trend with the medical device industry, allowing innovators to leverage the technical and regulatory expertise of contract service providers in order to expedite time to market

Roots Analysis is pleased to announce the publication of its recent study, titled, “Medical Device CROs for Regulatory Affairs Management Market, 2019-2030.”

For more information please click on the following link
https://www.rootsanalysis.com/reports/view_document/med-dev-regulatory/282.html

The report features a detailed study on the current landscape of contract service providers focused on regulatory affairs management for medical devices. The study features an in-depth analysis, highlighting the capabilities of the various CROs engaged in this domain, across different regions of the globe. Amongst other elements, the report includes:
A detailed review of the current market landscape of the medical devices regulatory affairs outsourcing market, featuring a list of over 400 CROs engaged in this domain.
A detailed discussion on the need for regulatory review / oversight across different stages of the medical devices supply chain, with emphasis on the optimization of the supply chain using upcoming tools / technologies.
An elaborate discussion on the various guidelines established by major regulatory bodies for medical device approval across North America, Europe, Asia-Pacific and rest of the world.
Elaborate profiles of popular players that specialize in offering end-to-end regulatory services for medical devices across key geographies.
A benchmark analysis, highlighting the key focus areas of very small-sized, small-sized, mid-sized and large companies, comparing their existing capabilities within and beyond their respective peer groups.
An elaborate discussion on the various outsourcing business models adopted for regulatory affairs management, along with an insightful Harvey ball analysis of key considerations that need to be assessed by industry stakeholders while selecting a CRO partner.
An analysis highlighting the key performance indicators used by sponsor companies to evaluate service providers that are active in the domain, based on information gathered via secondary research (for top-ten medical device players) and primary research.
A survey analysis featuring inputs solicited from various experts who are directly / indirectly involved in providing regulatory affairs management services to medical device developers.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

Medical Device Class
Class I
Class II
Class III

Therapeutic Area
Cardiovascular Disorders
CNS Disorders
Metabolic Disorders
Oncological Disorders
Ophthalmological Disease
Orthopedic Disorders
Pain Disorders
Respiratory Disorders
Others

Type of Regulatory Affairs Service
Pharmacies GAP-Analysis
Pharmacies Legal Representation
Pharmacies Notified Body Selection
Product Labelling-related Services
Product Registration and Clinical Trial Applications
Regulatory Document Submissions
Regulatory Writing and Publishing
Risk Management-related Services
Technical Dossier Set-up
Vigilance & Medical Device Report

Key Geographical Regions
North America
Europe
Asia-Pacific and Rest of the World

Key companies covered in the report
CTI Clinical Trial and Consulting Services
CROMSOURCE
ICON
Intertek
Medpace
MIC Medical
North American Science Associates (NAMSA)
Parexel
PharmaLex
Premier Research
Société Générale de Surveillance (SGS)
Underwriters Laboratory (UL)

For more information please click on the following link
https://www.rootsanalysis.com/reports/view_document/med-dev-regulatory/282.html

Other Recent Offerings
1. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market (3rd Edition), 2019-2030
2. Medical Device Labels Manufacturing Market, 2019-2030
3. Medical Device Contract Manufacturing Market, 2019-2030

Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com

Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The contract regulatory affairs-management services market for medical devices is estimated to be worth USD 820 million by 2030, growing at a CAGR of 6.9%, claims Roots Analysis here

News-ID: 2201234 • Views:

More Releases from Roots Analysis

Respiratory syncytial virus infections are recognized among the prevalent respiratory diseases, accounting for approximately 33 million new cases in children aged under five years, annually
Respiratory syncytial virus infections are recognized among the prevalent respir …
Currently, several traditional techniques are available for treating these infections, although none of them have been competent enough to reduce the healthcare burden of RSV diseases. In order to address this, RSV vaccines emerged as a promising alternative, which provides active immunity against the RSV infections, thus protecting the vulnerable population. Further, by providing targeted immunity, these vaccines help reducing the severity of RSV infections and lower the hospitalization rates
Rise in demand of glp-1 drugs for metabolic disorders.
Rise in demand of glp-1 drugs for metabolic disorders.
In recent years, owing to its broader clinical potential in the treatment of obesity and type 2 diabetes, along with their proven efficacy in reducing cardiovascular risks, GLP-1 drugs market has garnered significant traction within the medical science domain. Concurrently, the rising demand and escalating prevalence of metabolic disorder including type 2 diabetes and obesity are fueling the need for treatments capable of effectively managing these conditions. This trend is expected
Carbon footprint management market is Set to Soar to USD 55.9 Billion by 2035
Carbon footprint management market is Set to Soar to USD 55.9 Billion by 2035
Carbon footprint refers to the measurement of greenhouse gas emissions, expressed in carbon dioxide equivalent. It is released into the atmosphere either directly or indirectly through various activities, processes, or products. These emissions originate from diverse sources, including energy consumption, manufacturing processes, transportation networks, and waste management strategies. The global carbon footprint management market, valued at USD 12.2 billion in 2024, is expected to reach USD 13.5 billion in 2025
Gene switches have garnered significant attention from drug developers owing to their ability to control the activity of genetically modified cell products in vivo
Gene switches have garnered significant attention from drug developers owing to …
The global gene switch market size is estimated to grow from USD 795 million in 2025 to USD 2,478 million by 2035, representing a CAGR of 12.03% during the forecast period till 2035. Driven by numerous developmental breakthroughs and encouraging study results demonstrating the vast potential of adoptive cell therapies (ACT), including CAR-T cell therapies, TCR therapies, TILs and natural killer cell therapies, in the treatment of various complex disorders, this

All 5 Releases


More Releases for Disorders

Bleeding Disorders Market Is Driven By Bleeding Disorders In Various Industries, …
The Bleeding Disorders Market is a critical component of the healthcare industry, focused on the diagnosis, treatment, and management of bleeding disorders that affect individuals' blood clotting mechanisms. These disorders, which include hemophilia, von Willebrand disease, and various clotting factor deficiencies, can lead to prolonged and spontaneous bleeding, posing significant health risks. This market encompasses a range of therapies, medications, and diagnostic tools designed to address the unique needs of
Gene Therapy For Rare Disease Market By Therapeutic Application ( Oncology, Neur …
The Gene Therapy For Rare Disease Market report outlines the evolution of Gene Therapy For Rare Disease industry by type, applications and identifies and assesses the best performing vendors in the market till 2028. Gene Therapy For Rare Disease Market reports present the revenue opportunities in the Gene Therapy For Rare Disease industry through 2023-2028, highlighting the market size and growth by technology, geography, vertical and End users. Download Sample PDF
Neuroprosthetics Market 2019 Industry Segmentation by physiological disorders ar …
Neuroprosthetics Market 2019 Scenario Neuroprosthetics Market was estimated to be USD 5.28 billion in 2016 and expected to reach USD 10.48 billion by 2023. The key factors responsible for driving this are increasing in geriatric population, auditory processing disorders in kids, and increase in spinal cord treatment due to advancement in neuroprosthetics devices. The factors responsible for the positive growth of this market are increasing prevalence of neural diseases, over active bladder
11-29-2018 | Health & Medicine
Fact.MR
Global Vocal Biomarker Market to Experience Significant Growth during the Foreca …
Vocal patterns have been used by clinical psychologists and psychoanalysts for analyzing personality traits of patients, and helping creation of headway in clinical and medical investigations. Recent breakthroughs in the healthcare sector have led to the development of a unique diagnostic tool known as Vocal Biomarker Market by combining the concept of biological markers with the aforementioned methodology to analyze personality traits. Claim Sample Report For FREE: https://www.factmr.com/connectus/sample?flag=S&rep_id=719 These vocal biomarkers are
Behavioral Therapy Market Report 2018: Segmentation by Type (Anxiety Disorders, …
Global Behavioral Therapy market research report provides company profile for American Addiction Centers, ChanceLight, Haven Behavioral Healthcare, Behavioral Health Group, Center for Autism & Related Disorders, People’s Care, Magellan Health, Universal Health Services, Acadia Healthcare, Springstone and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY
Biopharmaceuticals Market Outlook 2025|( Biopharmaceuticals Application:- Infect …
Global Biopharmaceuticals Market Research Report Brief Focus On Study About Biopharmaceuticals Market Industry volume, Market Revenue, Market Segments , Market Trends ,Growth aspects A wide range of applications, Utilization ratio, Supply and demand analysis are also consist in the report such as: Biopharmaceuticals Product Type:- Monoclonal Antibodies, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Synthetic Immunomodulators, Vaccines, Biopharmaceuticals Application :- Inflammatory , Infectious Diseases, Autoimmune Disorders, Metabolic